Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R12 - Effective April 1, 2023 Mar 30, 2023
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R16 - Effective April 1, 2023 Mar 30, 2023
Billing and Coding: JW and JZ Modifier Billing Guidelines (A53024) - R6 - Effective January 10, 2023 Mar 02, 2023
Billing and Coding: Complex Drug Administration Coding (A58532) - R12 - Effective January 01, 2023 Mar 02, 2023
Billing and Coding: Routine Dental Services Article Retirement - January 1, 2023 Mar 02, 2023
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R5 - Effective January 01, 2023 Feb 27, 2023
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R5 - Effective January 01, 2023 Feb 27, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R10 - Effective January 01, 2023 Feb 24, 2023
Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices (A52966) - R14 - Effective October 1, 2022 Feb 01, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Know error (A55274) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R2 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R5 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: Botulinum Toxin Types A and B Policy (A57185) - R4 - Effective October 01, 2019 Jan 26, 2023
Billing and Coding: JW Modifier Billing Guidelines (A53024) - R5 - Effective January 10, 2023 Jan 23, 2023
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) - R1 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R8 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R9 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: myPap (A55292) - R4 - Effective January 1, 2023 Jan 12, 2023